Its food and medicine service South Korea announced today that it has finally approved the granting of the US-German consortium vaccine for emergency use Pfizer/BioNTech for the new coronavirus.
Seoul had already approved the use of a first batch of Pfizer product that arrived in the country last month through COVAX, a program led by the World Health Organization. These doses are already being used in the immunization campaign.
In addition, an urgent use permit was issued for the vaccine developed by the Swedish pharmaceutical industry AstraZeneca and the University of Oxford.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
